NICE set to approve trastuzumab emtansine for breast cancer

NHS England will routinely fund Kadcyla for people with advanced HER-2 positive cancer

Related items from OnMedica

Ovarian cancer drug may help stall breast cancer
The medicine price debate
Breast cancer drug ‘too costly’ for NHS
Experts recommend anastrozole for postmenopausal women with family history of breast cancer
Cancer-preventing drugs

from OnMedica News http://ift.tt/2rxBXPM
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s